Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis

Abstract Background The efficacy of dexmedetomidine in preventing postoperative delirium (POD) following cardiac surgery remains controversial. This systematic review aimed to evaluate whether dexmedetomidine could prevent POD in patients undergoing cardiac surgery. Methods PubMed, CENTRAL, and Emba...

Full description

Saved in:
Bibliographic Details
Main Authors: Yiyang Zhong, Zhizhen Ren, Jie Gao, Xingjian He, Qian Li
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-025-03264-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226024112357376
author Yiyang Zhong
Zhizhen Ren
Jie Gao
Xingjian He
Qian Li
author_facet Yiyang Zhong
Zhizhen Ren
Jie Gao
Xingjian He
Qian Li
author_sort Yiyang Zhong
collection DOAJ
description Abstract Background The efficacy of dexmedetomidine in preventing postoperative delirium (POD) following cardiac surgery remains controversial. This systematic review aimed to evaluate whether dexmedetomidine could prevent POD in patients undergoing cardiac surgery. Methods PubMed, CENTRAL, and Embase were searched up to 1 November 2024. Randomized controlled trials (RCTs) concerning dexmedetomidine for preventing POD in patients undergoing cardiac surgery were included. The primary outcome was the incidence of POD, and the secondary outcome was the incidence of postoperative atrial fibrillation (POAF). The analyses were performed using RevMan 5.3 and R 4.4.2 to calculate risk ratio (RR) with 95% confidence interval (CI). Trial sequential analysis (TSA) was conducted using TSA 0.9.5.10 Beta. Results Thirty-two studies with 6046 participants were included. Dexmedetomidine notably reduced the incidence of POD (RR = 0.67, 95% CI 0.59–0.76, P < 0.00001), with sufficient evidence and conclusive result from TSA. Dexmedetomidine was more effective in preventing POD compared with both positive control (RR = 0.47, 95% CI 0.38–0.59, P < 0.00001) and placebo control (RR = 0.83, 95% CI 0.70–0.98, P = 0.02). It reduced the incidence of POD not only in elderly patients (RR = 0.66, 95% CI 0.54–0.81, P < 0.0001) but also in normal age patients (RR = 0.68, 95% CI 0.57–0.80, P < 0.00001). Moreover, dexmedetomidine decreased the incidence of POAF (RR = 0.82, 95% CI 0.74–0.92, P = 0.0005). Conclusions Dexmedetomidine could reduce the incidence of POD in patients undergoing cardiac surgery and was associated with a decreased incidence of POAF. The findings should be interpreted with caution because of the low to moderate quality of evidence. Further trials are still needed to explore the optimal regimen of dexmedetomidine. Registration number: INPLASY2024110008.
format Article
id doaj-art-df382be5c75847af97cee7c0d6706bd5
institution Kabale University
issn 1471-2253
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj-art-df382be5c75847af97cee7c0d6706bd52025-08-24T11:47:33ZengBMCBMC Anesthesiology1471-22532025-08-0125111110.1186/s12871-025-03264-yDexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysisYiyang Zhong0Zhizhen Ren1Jie Gao2Xingjian He3Qian Li4West China School of Medicine and West China Hospital, Sichuan UniversityWest China School of Medicine and West China Hospital, Sichuan UniversityWest China School of Medicine and West China Hospital, Sichuan UniversitySchool of Medicine, The Chinese University of Hong KongWest China School of Medicine and West China Hospital, Sichuan UniversityAbstract Background The efficacy of dexmedetomidine in preventing postoperative delirium (POD) following cardiac surgery remains controversial. This systematic review aimed to evaluate whether dexmedetomidine could prevent POD in patients undergoing cardiac surgery. Methods PubMed, CENTRAL, and Embase were searched up to 1 November 2024. Randomized controlled trials (RCTs) concerning dexmedetomidine for preventing POD in patients undergoing cardiac surgery were included. The primary outcome was the incidence of POD, and the secondary outcome was the incidence of postoperative atrial fibrillation (POAF). The analyses were performed using RevMan 5.3 and R 4.4.2 to calculate risk ratio (RR) with 95% confidence interval (CI). Trial sequential analysis (TSA) was conducted using TSA 0.9.5.10 Beta. Results Thirty-two studies with 6046 participants were included. Dexmedetomidine notably reduced the incidence of POD (RR = 0.67, 95% CI 0.59–0.76, P < 0.00001), with sufficient evidence and conclusive result from TSA. Dexmedetomidine was more effective in preventing POD compared with both positive control (RR = 0.47, 95% CI 0.38–0.59, P < 0.00001) and placebo control (RR = 0.83, 95% CI 0.70–0.98, P = 0.02). It reduced the incidence of POD not only in elderly patients (RR = 0.66, 95% CI 0.54–0.81, P < 0.0001) but also in normal age patients (RR = 0.68, 95% CI 0.57–0.80, P < 0.00001). Moreover, dexmedetomidine decreased the incidence of POAF (RR = 0.82, 95% CI 0.74–0.92, P = 0.0005). Conclusions Dexmedetomidine could reduce the incidence of POD in patients undergoing cardiac surgery and was associated with a decreased incidence of POAF. The findings should be interpreted with caution because of the low to moderate quality of evidence. Further trials are still needed to explore the optimal regimen of dexmedetomidine. Registration number: INPLASY2024110008.https://doi.org/10.1186/s12871-025-03264-yDexmedetomidinePostoperative deliriumMeta-analysisTrial sequential analysis
spellingShingle Yiyang Zhong
Zhizhen Ren
Jie Gao
Xingjian He
Qian Li
Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis
BMC Anesthesiology
Dexmedetomidine
Postoperative delirium
Meta-analysis
Trial sequential analysis
title Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis
title_full Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis
title_fullStr Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis
title_full_unstemmed Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis
title_short Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis
title_sort dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery a systematic review and meta analysis with trial sequential analysis
topic Dexmedetomidine
Postoperative delirium
Meta-analysis
Trial sequential analysis
url https://doi.org/10.1186/s12871-025-03264-y
work_keys_str_mv AT yiyangzhong dexmedetomidineforthepreventionofpostoperativedeliriuminpatientsundergoingcardiacsurgeryasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT zhizhenren dexmedetomidineforthepreventionofpostoperativedeliriuminpatientsundergoingcardiacsurgeryasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT jiegao dexmedetomidineforthepreventionofpostoperativedeliriuminpatientsundergoingcardiacsurgeryasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT xingjianhe dexmedetomidineforthepreventionofpostoperativedeliriuminpatientsundergoingcardiacsurgeryasystematicreviewandmetaanalysiswithtrialsequentialanalysis
AT qianli dexmedetomidineforthepreventionofpostoperativedeliriuminpatientsundergoingcardiacsurgeryasystematicreviewandmetaanalysiswithtrialsequentialanalysis